Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells

Signal Transduction via Cannabinoid Receptors

(2012) George Dalton et al.   CNS & Neurological Disorders-Drug Targets

CB1cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

(2010) Partha Mukhopadhyay et al.   BRITISH JOURNAL OF PHARMACOLOGY

The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction

(2009) Shiang Y. Lim et al.   BASIC RESEARCH IN CARDIOLOGY

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

(2009) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction

(2009) Csaba Szabo   BRITISH JOURNAL OF PHARMACOLOGY

CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages

(2009) K. H. Han et al.   CARDIOVASCULAR RESEARCH

CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes

(2009) Partha Mukhopadhyay et al.   CARDIOVASCULAR RESEARCH

Endothelial Dysfunction

(2009) Paul M. Vanhoutte   CIRCULATION JOURNAL

Cannabinoid receptors as therapeutic targets in the management of liver diseases

(2009) A. Mallat et al.   DRUG NEWS & PERSPECTIVES

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy

(2009) Partha Mukhopadhyay et al.   FREE RADICAL BIOLOGY AND MEDICINE

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

(2009) P. Caraceni et al.   GUT

Endocannabinoids and the Heart

(2009) C Robin Hiley   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and Stroke

(2009) Ming Zhang et al.   Journal of Neuroimmune Pharmacology

CENTRAL CANNABINOID 1 RECEPTOR ANTAGONIST ADMINISTRATION PREVENTS ENDOTOXIC HYPOTENSION AFFECTING NOREPINEPHRINE RELEASE IN THE PREOPTIC ANTERIOR HYPOTHALAMIC AREA

(2009) Alex Villanueva et al.   SHOCK

Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice

(2008) Frédérique Dol-Gleizes et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cannabinoid CB 1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders

(2008) Pál Pacher   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation

(2008) Mohanraj Rajesh et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Guide to Receptors and Channels (GRAC), 3rd edition

(2008) S P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages

(2008) Koichi Sugamura et al.   CIRCULATION

Inflammation and endothelial dysfunction during aging: role of NF-κB

(2008) Anna Csiszar et al.   JOURNAL OF APPLIED PHYSIOLOGY

Dysregulation of the Endocannabinoid System in Obesity

(2008) S. Engeli   JOURNAL OF NEUROENDOCRINOLOGY

Targeting the endocannabinoid system: to enhance or reduce?

(2008) Vincenzo Di Marzo   NATURE REVIEWS DRUG DISCOVERY

CB2cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration

(2007) M Rajesh et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning

(2007) P Pacher et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoid receptors in acute and chronic complications of atherosclerosis

(2007) F Mach et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions

(2007) V E Mendizábal et al.   BRITISH JOURNAL OF PHARMACOLOGY